Literature DB >> 11571635

Telomere lengths and telomerase activity in dog tissues: a potential model system to study human telomere and telomerase biology.

L Nasir1, P Devlin, T Mckevitt, G Rutteman, D J Argyle.   

Abstract

Studies on telomere and telomerase biology are fundamental to the understanding of aging and age-related diseases such as cancer. However, human studies have been hindered by differences in telomere biology between humans and the classical murine animal model system. In this paper, we describe basic studies of telomere length and telomerase activity in canine normal and neoplastic tissues and propose the dog as an alternative model system. Briefly, telomere lengths were measured in normal canine peripheral blood mononuclear cells (PBMCs), a range of normal canine tissues, and in a panel of naturally occurring soft tissue tumours by terminal restriction fragment (TRF) analysis. Further, telomerase activity was measured in canine cell lines and multiple canine tissues using a combined polymerase chain reaction/enzyme-linked immunosorbent assay method. TRF analysis in canine PBMCs and tissues demonstrated mean TRF lengths to range between 12 and 23 kbp with heterogeneity in telomere lengths being observed in a range of normal somatic tissues. In soft tissue sarcomas, two subgroups were identified with mean TRFs of 22.2 and 18.2 kbp. Telomerase activity in canine tissue was present in tumour tissue and testis with little or no activity in normal somatic tissues. These results suggest that the dog telomere biology is similar to that in humans and may represent an alternative model system for studying telomere biology and telomerase-targeted anticancer therapies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11571635      PMCID: PMC1505860          DOI: 10.1038/sj.neo.7900173

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  39 in total

1.  Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals.

Authors:  H Iwama; K Ohyashiki; J H Ohyashiki; S Hayashi; N Yahata; K Ando; K Toyama; A Hoshika; M Takasaki; M Mori; J W Shay
Journal:  Hum Genet       Date:  1998-04       Impact factor: 4.132

2.  Telomere length in fibroblasts and blood cells from healthy centenarians.

Authors:  C Mondello; C Petropoulou; D Monti; E S Gonos; C Franceschi; F Nuzzo
Journal:  Exp Cell Res       Date:  1999-04-10       Impact factor: 3.905

3.  Disease states associated with telomerase deficiency appear earlier in mice with short telomeres.

Authors:  E Herrera; E Samper; J Martín-Caballero; J M Flores; H W Lee; M A Blasco
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

4.  Longevity, stress response, and cancer in aging telomerase-deficient mice.

Authors:  K L Rudolph; S Chang; H W Lee; M Blasco; G J Gottlieb; C Greider; R A DePinho
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

5.  Measurement of telomerase activity in dog tumors.

Authors:  M Yazawa; M Okuda; A Setoguchi; R Nishimura; N Sasaki; A Hasegawa; T Watari; H Tsujimoto
Journal:  J Vet Med Sci       Date:  1999-10       Impact factor: 1.267

Review 6.  Cancer, aging and cellular senescence.

Authors:  J Campisi
Journal:  In Vivo       Date:  2000 Jan-Feb       Impact factor: 2.155

7.  On telomere shortening in soft-tissue tumors.

Authors:  R Schneider-Stock; C Epplen; K Radig; Y Oda; H Dralle; C Hoang-Vu; J T Epplen; A Roessner
Journal:  J Cancer Res Clin Oncol       Date:  1998       Impact factor: 4.553

8.  Evaluation of an assay for detecting telomerase activity in neoplastic tissues of dogs.

Authors:  B J Biller; B E Kitchell; C D Cadile
Journal:  Am J Vet Res       Date:  1998-12       Impact factor: 1.156

9.  Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines.

Authors:  G J TODARO; H GREEN
Journal:  J Cell Biol       Date:  1963-05       Impact factor: 10.539

10.  Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice.

Authors:  M P Hande; E Samper; P Lansdorp; M A Blasco
Journal:  J Cell Biol       Date:  1999-02-22       Impact factor: 10.539

View more
  30 in total

1.  A vaccine targeting telomerase enhances survival of dogs affected by B-cell lymphoma.

Authors:  Daniela Peruzzi; Alessandra Gavazza; Giuseppe Mesiti; George Lubas; Elisa Scarselli; Antonella Conforti; Claus Bendtsen; Gennaro Ciliberto; Nicola La Monica; Luigi Aurisicchio
Journal:  Mol Ther       Date:  2010-06-08       Impact factor: 11.454

2.  Telomeres shorten more slowly in long-lived birds and mammals than in short-lived ones.

Authors:  Mark F Haussmann; David W Winkler; Kathleen M O'Reilly; Charles E Huntington; Ian C T Nisbet; Carol M Vleck
Journal:  Proc Biol Sci       Date:  2003-07-07       Impact factor: 5.349

3.  Interaction between Bovine leukemia virus (BLV) infection and age on telomerase misregulation.

Authors:  Farhid Hemmatzadeh; Hadi Keyvanfar; Noor Haliza Hasan; Faustina Niap; Ebrahim Bani Hassan; Azar Hematzade; Esmaeil Ebrahimie; Andrea McWhorter; Jagoda Ignjatovic
Journal:  Vet Res Commun       Date:  2015-02-11       Impact factor: 2.459

4.  Telomerase activity coevolves with body mass not lifespan.

Authors:  Andrei Seluanov; Zhuoxun Chen; Christopher Hine; Tais H C Sasahara; Antonio A C M Ribeiro; Kenneth C Catania; Daven C Presgraves; Vera Gorbunova
Journal:  Aging Cell       Date:  2006-12-14       Impact factor: 9.304

Review 5.  Animal models of human genetic diseases: do they need to be faithful to be useful?

Authors:  Jean-Louis Guénet
Journal:  Mol Genet Genomics       Date:  2011-05-06       Impact factor: 3.291

Review 6.  The non-canonical functions of telomerase: to turn off or not to turn off.

Authors:  Aleksandra Romaniuk; Anna Paszel-Jaworska; Ewa Totoń; Natalia Lisiak; Hanna Hołysz; Anna Królak; Sylwia Grodecka-Gazdecka; Błażej Rubiś
Journal:  Mol Biol Rep       Date:  2018-11-17       Impact factor: 2.316

7.  A model of canine leukocyte telomere dynamics.

Authors:  Athanase Benetos; Masayuki Kimura; Carlos Labat; Gerald M Buchoff; Shell Huber; Laura Labat; Xiaobin Lu; Abraham Aviv
Journal:  Aging Cell       Date:  2011-10-07       Impact factor: 9.304

8.  Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma.

Authors:  Alessandra Gavazza; George Lubas; Arthur Fridman; Daniela Peruzzi; Joseph A Impellizeri; Laura Luberto; Emanuele Marra; Giuseppe Roscilli; Gennaro Ciliberto; Luigi Aurisicchio
Journal:  Hum Gene Ther       Date:  2013-08       Impact factor: 5.695

Review 9.  Coevolution of telomerase activity and body mass in mammals: from mice to beavers.

Authors:  Vera Gorbunova; Andrei Seluanov
Journal:  Mech Ageing Dev       Date:  2008-02-23       Impact factor: 5.432

10.  Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer.

Authors:  Deli Liu; Huan Xiong; Angela E Ellis; Nicole C Northrup; Carlos O Rodriguez; Ruth M O'Regan; Stephen Dalton; Shaying Zhao
Journal:  Cancer Res       Date:  2014-07-31       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.